Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.
Ma F, Guan Y, Yi Z, Chang L, Li Q, Chen S, Zhu W, Guan X, Li C, Qian H, Xia X, Yang L, Zhang J, Husain H, Liao Z, Futreal A, Huang J, Yi X, Xu B.
Ma F, et al.
Int J Cancer. 2020 Mar 1;146(5):1359-1368. doi: 10.1002/ijc.32536. Epub 2019 Jul 4.
Int J Cancer. 2020.
PMID: 31241775
Clinical Trial.